Patent details

Basic Information

Publication number:

EP3912634

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP211620778

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CANCER STEM CELL TARGETED CANCER VACCINES

French Title of Invention:

VACCINS CONTRE LE CANCER CIBLANT DES CELLULES SOUCHES CANCÉREUSES

German Title of Invention:

GEGEN KREBSSTAMMZELLEN GERICHTETE TUMORIMPFSTOFFE

SPC Number:

Dates

Filing date:

15/05/2013

Grant date:

04/10/2023

EP Publication Date:

24/11/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/10/2023

EP B1 Publication Date:

04/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/05/2024

Expiration date:

15/05/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/09/2023

 

 

Name:

Stemline Therapeutics Inc.

Address:

750 Lexington Avenue, 11th Floor, New York, NY 10022, United States (US)

Inventor

1

Name:

CIRRITO, Thomas, P.

Address:

United States (US)

2

Name:

BROOKS, Christopher

Address:

United States (US)

3

Name:

BERGSTEIN, Ivan

Address:

United States (US)

Priority

Priority Number:

201261647615 P

Priority Date:

16/05/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 31/437; A61K 38/20; A61K 38/30; A61K 39/00; A61K 35/00; A61P 37/04; A61P 43/00; A61K 38/17; A61K 38/21; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202340

Publication date:

04/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages